These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 36331758)

  • 1. Novel naturally occurring autoantibodies attenuate α-synuclein pathology in a mouse model of Parkinson's disease.
    Li Y; Wang T; Meng L; Jin L; Liu C; Liang Y; Ren L; Liu Y; Liu Y; Liu S; Li T; Liang Y; Chen X; Zhang Z
    Neuropathol Appl Neurobiol; 2023 Feb; 49(1):e12860. PubMed ID: 36331758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain iron enrichment attenuates α-synuclein spreading after injection of preformed fibrils.
    Dauer Née Joppe K; Tatenhorst L; Caldi Gomes L; Zhang S; Parvaz M; Carboni E; Roser AE; El DeBakey H; Bähr M; Vogel-Mikuš K; Wang Ip C; Becker S; Zweckstetter M; Lingor P
    J Neurochem; 2021 Nov; 159(3):554-573. PubMed ID: 34176164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naturally occurring autoantibodies against α-synuclein rescues memory and motor deficits and attenuates α-synuclein pathology in mouse model of Parkinson's disease.
    Huang YR; Xie XX; Ji M; Yu XL; Zhu J; Zhang LX; Liu XG; Wei C; Li G; Liu RT
    Neurobiol Dis; 2019 Apr; 124():202-217. PubMed ID: 30481547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathy.
    Earls RH; Menees KB; Chung J; Gutekunst CA; Lee HJ; Hazim MG; Rada B; Wood LB; Lee JK
    Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1762-1771. PubMed ID: 31900358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α-Synuclein Propagation Mouse Models of Parkinson's Disease.
    Uemura N; Ueda J; Okuda S; Sawamura M; Takahashi R
    Methods Mol Biol; 2021; 2322():119-130. PubMed ID: 34043198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of de novo α-synuclein fibrillization in a neuronal model for Parkinson's disease.
    Fares MB; Maco B; Oueslati A; Rockenstein E; Ninkina N; Buchman VL; Masliah E; Lashuel HA
    Proc Natl Acad Sci U S A; 2016 Feb; 113(7):E912-21. PubMed ID: 26839406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preformed fibrils generated from mouse alpha-synuclein produce more inclusion pathology in rats than fibrils generated from rat alpha-synuclein.
    Howe JW; Sortwell CE; Duffy MF; Kemp CJ; Russell CP; Kubik M; Patel P; Luk KC; El-Agnaf OMA; Patterson JR
    Parkinsonism Relat Disord; 2021 Aug; 89():41-47. PubMed ID: 34218047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel conformation-selective alpha-synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's disease.
    Covell DJ; Robinson JL; Akhtar RS; Grossman M; Weintraub D; Bucklin HM; Pitkin RM; Riddle D; Yousef A; Trojanowski JQ; Lee VM
    Neuropathol Appl Neurobiol; 2017 Dec; 43(7):604-620. PubMed ID: 28386933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Α-synuclein immunotherapy blocks uptake and templated propagation of misfolded α-synuclein and neurodegeneration.
    Tran HT; Chung CH; Iba M; Zhang B; Trojanowski JQ; Luk KC; Lee VM
    Cell Rep; 2014 Jun; 7(6):2054-65. PubMed ID: 24931606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-dose intranasal administration of α-syn PFFs induce lewy neurite-like pathology in olfactory bulbs.
    Sawamura M; Ohira J; Hikawa R; Ishimoto T; Nakanishi E; Yamakado H; Takahashi R
    Parkinsonism Relat Disord; 2023 Jul; 112():105440. PubMed ID: 37267818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy.
    Nimmo JT; Verma A; Dodart JC; Wang CY; Savistchenko J; Melki R; Carare RO; Nicoll JAR
    Alzheimers Res Ther; 2020 Nov; 12(1):159. PubMed ID: 33256825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inoculation of α-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve.
    Uemura N; Yagi H; Uemura MT; Hatanaka Y; Yamakado H; Takahashi R
    Mol Neurodegener; 2018 May; 13(1):21. PubMed ID: 29751824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Slow Progressive Accumulation of Oligodendroglial Alpha-Synuclein (α-Syn) Pathology in Synthetic α-Syn Fibril-Induced Mouse Models of Synucleinopathy.
    Uemura N; Uemura MT; Lo A; Bassil F; Zhang B; Luk KC; Lee VM; Takahashi R; Trojanowski JQ
    J Neuropathol Exp Neurol; 2019 Oct; 78(10):877-890. PubMed ID: 31504665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of naturally occurring α-synuclein-antibodies on toxic α-synuclein-fragments.
    Rabenstein M; Besong Agbo D; Wolf E; Dams J; Nicolai M; Roeder A; Bacher M; Dodel RC; Noelker C
    Neurosci Lett; 2019 Jun; 704():181-188. PubMed ID: 30954607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of phosphorylated α-synuclein in Macaca fuscata.
    Kawakami I; Motoda A; Hashimoto M; Shimozawa A; Masuda-Suzukake M; Ohtani R; Takase M; Kumashiro M; Samejima K; Hasegawa M
    Brain Pathol; 2021 Sep; 31(5):e12952. PubMed ID: 33754430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological Inhibition of Brain EGFR Activation By a BBB-penetrating Inhibitor, AZD3759, Attenuates α-synuclein Pathology in a Mouse Model of α-Synuclein Propagation.
    Tavassoly O; Del Cid Pellitero E; Larroquette F; Cai E; Thomas RA; Soubannier V; Luo W; Durcan TM; Fon EA
    Neurotherapeutics; 2021 Apr; 18(2):979-997. PubMed ID: 33713002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T Cells Limit Accumulation of Aggregate Pathology Following Intrastriatal Injection of α-Synuclein Fibrils.
    George S; Tyson T; Rey NL; Sheridan R; Peelaerts W; Becker K; Schulz E; Meyerdirk L; Burmeister AR; von Linstow CU; Steiner JA; Galvis MLE; Ma J; Pospisilik JA; Labrie V; Brundin L; Brundin P
    J Parkinsons Dis; 2021; 11(2):585-603. PubMed ID: 33579871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-synuclein fibrils amplified from multiple system atrophy and Parkinson's disease patient brain spread after intracerebral injection into mouse brain.
    Zhang S; Dauer K; Strohäker T; Tatenhorst L; Caldi Gomes L; Mayer S; Jung BC; Kim WS; Lee SJ; Becker S; Liesche-Starnecker F; Zweckstetter M; Lingor P
    Brain Pathol; 2023 Sep; 33(5):e13196. PubMed ID: 37485772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-Synuclein Preformed Fibrils Bind to β-Neurexins and Impair β-Neurexin-Mediated Presynaptic Organization.
    Feller B; Fallon A; Luo W; Nguyen PT; Shlaifer I; Lee AK; Chofflet N; Yi N; Khaled H; Karkout S; Bourgault S; Durcan TM; Takahashi H
    Cells; 2023 Apr; 12(7):. PubMed ID: 37048156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau accelerates α-synuclein aggregation and spreading in Parkinson's disease.
    Pan L; Li C; Meng L; Tian Y; He M; Yuan X; Zhang G; Zhang Z; Xiong J; Chen G; Zhang Z
    Brain; 2022 Oct; 145(10):3454-3471. PubMed ID: 35552614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.